41
Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre for Reproductive Medicine Brussels

Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Embed Size (px)

Citation preview

Page 1: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Testicular Function after Cytotoxic Therapy

International Symposium on Reproductive MedicineIstanbulJune 4-6, 2010

Herman Tournaye, M.D. Ph.D.Centre for Reproductive Medicine Brussels

Page 2: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

outline of the lecture

• the testis: a brief introduction

• effects on the endocrine function

• effects on the exocrine function

• take-home messages

Page 3: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

ww

w.inquisitr.com

/wp-content/conflict.jpg

The speaker declares no conflict of interest with

the topic presented in this lecture

Page 4: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

outline of the lecture

• the testis: a brief introduction

• effects on the endocrine function

• effects on the exocrine function

• take-home messages

Page 5: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 6: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 7: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

differentiation Clermont 1976Ehmcke et al. 2005

Ad/Ap-model of stem cell renewal

Page 8: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 9: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 10: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

http://www.enlarged-prostate-treatment.info

Page 11: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

outline of the lecture

• the testis: a brief introduction

• effects on the endocrine function

• effects on the exocrine function

• take-home messages

Page 12: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

• less sensitive than germinal epithelium:

slighly elevated LHmild testosterone deficiency to normal(Shalet et al. 1999; Chatterjee et al. 1994)

• more prone to irradiation damage in pre-pubertal life (Shalet et al. 1989)

and if radiation dose >2400 cGy

Leydig cell function after CT / RT

Page 13: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

• some of these men with subnormal testosterone levels show reduced bone density(Howell et al. 2000)

• blinded placebo controlled RCT shows no benefit/ indication for androgens(Howell et al. 2001)

Leydig cell function after CT / RT

Page 14: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

outline of the lecture

• the testis: a brief introduction

• effects on the endocrine function

• effects on the exocrine function

• take-home messages

Page 15: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

www.uh.edu/~tgill2/image016.jpg

Page 16: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Sharpe et al. 2003

Sertoli cell function after CT / RT

Page 17: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

• controversy on action on Sertoli cells

• unaffected when not replicating(Orth et al. 1988; Jégou et al. 1993)

• indirect effect on FSH through loss of germ cells (Jégou et al. 1993)

Sertoli cell function after CT / RT

Page 18: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Sertoli cell function after CT / RT

• CT @ age 13• testisbiopsy @ age 31

• unexpected expression ofcytokeratin-18 in 13% oftubuli (prepubertal marker)

• cytotoxic effect ?

Page 19: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 20: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Effect of single dose RT

Rowley et al. 1974, Howell & Shalet 2005

Page 21: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

• > because of scattered irradiation

• increased gonadotoxicity vs single-dose

• 1.2 Gy = treshold for permanent testicular damage without recovery in most patients

• TBI (>10 Gy): ≤ 1% fatherhood (Sanders et al.)

Effect of fractionated RT

Page 22: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

• interference with DNA & RNA synthesis(antimetabolites e.g. fluorouracil)

• inhibition of protein synthesis (alkylating e.g. cyclophosphamide,busulfan)

• interference with microtubule function(plant alkaloids e.g. vincristine, taxanes)

Effect of CT

Page 23: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 24: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

“Fertility-friendly chemotherapy”

• no chemotherapy guarantees 100% fertility

• oligozoospermia ≠ fertility

• risk aneuploidy and mutagenesis

• you never know the final treatment course

Page 25: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

A survey among patients

• 904 male cancer patients 14-40 yrs old

• Texas and Ohio

• 27% response rate (n=201, 8% refused survey)

• want children after cure? 51% overall

77% of childless

• informed about infertility?: only 60%

• informed about banking semen?: only 51%

• banked semen?: 24% (27% of childless)

Schover et al., J. Clin. Oncol. 2002

Page 26: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 27: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 28: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

The myth of the ‘testicular quiescence’

Page 29: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Induction of ‘testicular quiescence’

Page 30: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 31: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Testis is ‘quietly active’ rather than ‘truly quiescent’

Kelnar et al. H

um. R

eprod. 2002

Control marmoset GnRHa-treated marmoset

Page 32: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 33: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 34: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

>80% risk for sterility after cytostatic treatment

whole body irradiation

conditioning for bone-marrow transplantation

Hodgkin treated with alkylating agents

metastatic Ewing’s sarcoma

metastatic soft-tissue sarcoma

testicular radiotherapy

Wallace et al. Lancet Oncol. 2005

Page 35: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Distribution Children’s Cancer Research Group UK

Anderson et al. Hum. Reprod. 2008

Page 36: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Anderson et al. Hum. Reprod. 2008

risk for sterility after cytostatic treatment

Page 37: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre
Page 38: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

outline of the lecture

• the testis: a brief introduction

• effects on the endocrine function

• effects on the exocrine function

• take-home messages

Page 39: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Leydig cell deficiency

• clinically not important for most men

• no indication for routine substitution

• 'vigilant' management

Take-home messages

Page 40: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre

Spermatogenesis

• non-proliferative Sertoli cells are resistant

• no quiescent prepubertal stage

• all patients need proper counseling

• cryobanking in adults and children

Take-home messages

Page 41: Testicular Function after Cytotoxic Therapy International Symposium on Reproductive Medicine Istanbul June 4-6, 2010 Herman Tournaye, M.D. Ph.D. Centre